title: Re: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
authors.forename: Raphael B
authors.initials: RB
authors.lastname: Stricker
authors.forename: Lorraine
authors.initials: L
authors.lastname: Johnson
mesh_terms: D000900:Anti-Bacterial Agents / Q000592:standards* / Q000627:therapeutic use*; D002908:Chronic Disease / Q000628:therapy; D002985:Clinical Protocols / Q000592:standards; D016265:Conflict of Interest / Q000331:legislation & jurisprudence*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine / Q000941:ethics / Q000592:standards; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy*; D009462:Neurology / Q000941:ethics* / Q000592:standards; D017410:Practice Guidelines as Topic / Q000592:standards*; D012955:Societies, Medical / Q000941:ethics*; D028761:Withholding Treatment / Q000941:ethics / Q000592:standards
chemical_list: D000900:Anti-Bacterial Agents